Sunday, November 1, 2026

Back to today

From X

@convequity 2 clicks

Convequity on X

More $NVDA chips could end up going to SpaceX and other buyers that can borrow at investment-grade rates, leaving neoclouds with fewer chips than they need. SpaceX's planned $40bn chip borrowing shows why. The deal: $SPCX is in early talks for about $10bn of bank loans and $30bn of investment-grade debt, led by Apollo, with Pimco also in talks. It would close in 2027, and the talks could still fall apart. The comparison: in December, Apollo lent about $3.5bn to fund xAI's Colossus 2 chips through a separate company set up just for that deal. The interest rate was about 10% a year. xAI is now part of SpaceX. Investment-grade debt usually costs much less. US investment-grade corporate bonds yield around 6% on average today. The rate on the new $30bn has not been reported, so we don't know the exact saving yet. Why it could be cheaper: lenders would be relying on SpaceX's launch and Starlink businesses to repay, not only on the chips. That is the real financial payoff of putting xAI inside SpaceX. Most GPU buyers can't borrow like that. $CRWV is rated junk (Moody's Ba3, Fitch BB-) and pays 9.25% on its 2030 bonds. Standalone AI labs have no public credit ratings that we could find. Not every neocloud pays up. $NBIS has a GPU loan at a floating benchmark rate plus 2.5%, against CoreWeave's plus 5.5%. Our view: the debate on X is whether this proves AI demand or shows too much leverage. We think the bigger point is cost of capital. When chips are scarce, the buyer that borrows most cheaply can pay for the most of them, and neoclouds paying junk-level rates get squeezed out.

When the liquidity does not add up

Arbor Realty Trust’s dividend suspension is presented as creating $60 million of liquidity, raising questions about its ability to meet…

FTAI 3Q26: Aero margins in focus

FTAI’s Aerospace Products margin rebounded to 31% as CFM56 module output rose, while Power deposits and contracted deliveries fund its 2027…

CVX Earnings Review

Chevron’s Q3 revenue rose 35% to $65.2 billion and EBITDA 75% to $20.2 billion, while production trailed guidance and refining margins…

T · short

At&t INC

AT&T’s stalled deleveraging and share repurchase case has prompted a bearish turn on the telecom stock.

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

Another Haircut with Avy the Barber

SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.